Last reviewed · How we verify

NCT05673174

Avicena LVDP Validation Study in Healthy Volunteers

Completed Last updated 6 January 2023
What this trial tests

trial testing Non-Invasive Estimation of Left Ventricular Diastolic Pressure in Healthy in 321 participants. Completed in 30 August 2022.

Timeline
16 June 2022
Primary endpoint
30 August 2022
30 August 2022

Quick facts

Lead sponsorAvicena LLC
StatusCompleted
Study typeOBSERVATIONAL
Enrollment321
Start date16 June 2022
Primary completion30 August 2022
Estimated completion30 August 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Avicena LLC

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to document the utility of the Vivio System in quantifying LVDP in healthy volunteers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Avicena LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05673174.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing